Cargando…
Rare diseases and orphan drugs: Latvian story
BACKGROUND: Ten years have passed since Latvia became a Member State of the EU in 2004. As a result European regulations, including those related to rare diseases and orphan drugs, have been applied to Latvian legislative system. Orphan diseases have been recognized as a priority area for action in...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172941/ https://www.ncbi.nlm.nih.gov/pubmed/25231378 http://dx.doi.org/10.1186/s13023-014-0147-z |